Real-World Outcomes

Hospital-based end-of-life care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient.
Perceptions of patients with cancer regarding secondary data use is essential to informing the implementation of oncology learning systems.
Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ.
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib.